RYNE Biotechnology Inc.
Cambridge, US · Founded 2022 · 2 known investors
Biotech
Founders & leadership
JG
Jeff GoaterDirector
PF
Peter FuhrkenDirector
HF
Howard FederoffExecutive Officer, Director
NM
Nick ManusosExecutive Officer, Director
DF
David FallaceDirector
JJ
Jeff JonasDirector
MO
Martin OstrowskiExecutive Officer
JY
Jonathan YehDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$30MraisedMar 2024 · 9 investors · BiotechnologyRule 506(b)
▶$30MraisedMar 2024 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeff GoaterDirector
- Peter FuhrkenDirector
- Howard FederoffExecutive Officer, Director
- Nick ManusosExecutive Officer, Director
- David FallaceDirector
- Jeff JonasDirector
- Martin OstrowskiExecutive Officer
- Jonathan YehDirector
- Offering amount
- $81.8M
- Amount sold
- $30M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$3MraisedJul 2022 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedJul 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Howard FederoffDirector
- Jonathan YehExecutive Officer, Director
- Nick ManusosExecutive Officer, Director
- Carter CliffDirector
- Offering amount
- $5M
- Amount sold
- $3M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.